NCT04097925View on ClinicalTrials.gov

Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 18, 2020

Primary Completion Date

August 24, 2020

Study Completion Date

August 24, 2020

Conditions
HIV-1-infection
Interventions
DRUG

Doravirine

Doravirine 100 mg tablet

DRUG

Descovy

Tenofovir alafenamide 25 mg / emtricitabine 200 mg tablet

Trial Locations (1)

08907

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

All Listed Sponsors
collaborator

Institut d'Investigació Biomèdica de Bellvitge

OTHER

collaborator

Hospital Universitari de Bellvitge

OTHER

lead

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

OTHER

NCT04097925 - Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals | Biotech Hunter | Biotech Hunter